Michael Alred is a pharmacist who is specialized in Geriatric in Maumelle, Arkansas. Patients can reach him at 133 Manitou Dr, Maumelle or contact him on 501-851-1649. Active license number of Michael Alred is PD06429 for Geriatric in Arkansas. Michael Alred is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Michael Alred speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Michael Alred
Specialization:
Geriatric
Credentials:
PHARMD
Gender:
Male
Location:
133 Manitou Dr, Maumelle, Arkansas, 72113-5874
Phone:
501-851-1649
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Michael Alred are as mentioned below.
NPI Number:
1710165659
NPI Enumeration Date:
02 Feb, 2008
NPI Last Update On:
02 Feb, 2008
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michael Alred are as mentioned below.
Specialization
License Number
State
Status
Geriatric
PD06429
Arkansas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
133 Manitou Dr, Maumelle, Arkansas
Zip:
72113-5874
Phone Number:
501-851-1649
Fax Number:
--
Patients can reach Michael Alred at 133 Manitou Dr, Maumelle, Arkansas or can call on phone at 501-851-1649.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.